Matches in Nanopublications for { ?s ?p "[Resistance to anti?human epidermal growth factor receptor, hormonal or anti-PI3K therapies have been described in breast carcinomas bearing activation of the PI3K signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[Resistance to anti?human epidermal growth factor receptor, hormonal or anti-PI3K therapies have been described in breast carcinomas bearing activation of the PI3K signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1043181.RAVT1FmGKtF4zLq1JzjxjfiTmRGiQn576Mz8GjFtYsxA8130_assertion description "[Resistance to anti?human epidermal growth factor receptor, hormonal or anti-PI3K therapies have been described in breast carcinomas bearing activation of the PI3K signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1043181.RAVT1FmGKtF4zLq1JzjxjfiTmRGiQn576Mz8GjFtYsxA8130_provenance.
- NP1043182.RAaCNOMzkzMFqZNszidm43F6iVgxsQHMZwe80zXjgQAV0130_assertion description "[Resistance to anti?human epidermal growth factor receptor, hormonal or anti-PI3K therapies have been described in breast carcinomas bearing activation of the PI3K signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1043182.RAaCNOMzkzMFqZNszidm43F6iVgxsQHMZwe80zXjgQAV0130_provenance.
- NP1043183.RADTMq9Uib65R6-CnOUbi_ejpG1B8M2qnfQbXY_xcLJrU130_assertion description "[Resistance to anti?human epidermal growth factor receptor, hormonal or anti-PI3K therapies have been described in breast carcinomas bearing activation of the PI3K signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1043183.RADTMq9Uib65R6-CnOUbi_ejpG1B8M2qnfQbXY_xcLJrU130_provenance.
- NP1043184.RA-6GJRkCc4z0cTownijcepKsO9P0jHZkQ5A0THx5oMUY130_assertion description "[Resistance to anti?human epidermal growth factor receptor, hormonal or anti-PI3K therapies have been described in breast carcinomas bearing activation of the PI3K signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1043184.RA-6GJRkCc4z0cTownijcepKsO9P0jHZkQ5A0THx5oMUY130_provenance.